



Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Ab Initio Modeling is a computational approach used by Creative Biostructure to predict the three-dimensional structures of target proteins and complexes, providing valuable insights into their structure-function relationships for drug discovery. This technique is particularly useful when experimental methods for determining structures encounter technical difficulties.
Typology: Slides
1 / 6
This page cannot be seen from the preview
Don't miss anything!




Structural Modeling of Target Molecule Obtaining structural information about individual target proteins or complexes of target proteins with other molecules ( e.g. , proteins, nucleic acids, and small molecules) can provide insight into the structure-function relationship of the target protein and the underlying mechanism of interaction, which is significant for drug discovery and development. However, it is relatively difficult and time- consuming to determine the three-dimensional (3D) structure of biological macromolecules through experimental approaches such as X-ray crystallography, cryo-electron microscopy, or NMR spectroscopy. As a structure- based drug discovery CRO, Creative Biostructure not only provides experimental techniques to determine the structure, but also utilizes high- performance computing tools to predict the structural model of the target molecule, collect information about dynamic properties, and predict binding patterns and affinity between target proteins and other interacting molecules.
Creative Biostructure has extensive expertise and rich experience in generating structural models of various types of proteins and complexes. We mainly adopt two strategies for building target models, namely homology modeling and ab initio modeling, and we can also customize and perform target modeling according to customer requirements. We ensure the reliability of the resulting model for downstream applications, such as virtual screening and structure-based drug design guidance, through rigorous parameter setting and iterative computational validation and simulation.